The sympathomimetic agonist mirabegron did not lower JAK2-V617F allele burden, but restored nestin-positive cells and reduced reticulin fibrosis in patients with myeloproliferative neoplasms: results of phase 2 study SAKK 33/14
| Image |  |
|---|---|
| Description | scientific article published on 08 November 2018 |
| Author/s |
author: Alexandar Tzankov Swiss Group for Clinical Cancer Research Jakob R. Passweg Simón Méndez-Ferrer Alexandre P A Theocharides |
| Publication date | November 8, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |